Mass Tort Lawsuits

The Supreme Court's June 25, 2026 ruling in Monsanto v. Durnell held that FIFRA can preempt state failure-to-warn claims, unsettling a central theory in paraquat cases. With 6,666 actions pending in MDL 3004 and a global settlement agreed in principle but no terms disclosed, here is what is verified and what is not.

Quick Answer: The Suboxone dental injury lawsuit update for August 2026 centers on MDL 3092, the federal litigation involving claims that Suboxone (buprenorphine/naloxone) sublingual film caused serious dental injuries. Plaintiffs allege prolonged exposure to the film contributed to tooth decay, dental erosion, fractured teeth and tooth loss, and that adequate dental warnings were not provided [...]

Quick Answer: The Depo-Provera lawsuit statute of limitations typically runs one to six years from the date of diagnosis, depending on your state and whether that state applies a "discovery rule." Missing your state's deadline can bar your claim entirely, so confirming your exact filing window with an attorney as soon as possible is critical. [...]

Quick Answer: As of July 2026, Johnson & Johnson's talc bankruptcy strategy has failed for a third time, and talcum powder trials are actively resuming in state and federal courts. Settlement amounts vary widely by diagnosis severity, and claimants with ovarian cancer or mesothelioma diagnoses linked to long-term talc use may still qualify to file. [...]

An updated look at the J&J talcum powder MDL: pending claim counts, the March 2026 Lancet retraction, June 2026's split bellwether verdicts, the reduced punitive damages ruling, and where settlement talks stand.

The Depo-Provera Rule 702 hearing on general causation moves to July 27, 2026. Here's what the ruling could mean if your case isn't covered by the settlement.

Here's the PFAS lawsuit update for July 2026: the massive AFFF firefighting-foam litigation (MDL 2873) now has roughly 15,240 cases pending in South Carolina federal court, the first personal-injury bellwether trial remains off the calendar, and no personal-injury settlement has been announced; 3M’s July 2026 securities filing said the injury claims were in court-ordered mediation. [...]

Quick Answer: SSDI's biggest 2026 changes include a 2.8% cost-of-living adjustment that raises the average monthly disability payment to about $1,630, along with higher work and earnings limits and faster claim processing initiatives at the Social Security Administration. These updates apply automatically to current and new SSDI recipients. Published by: Mason Arnao | Primary Sources: [...]

Survivor- and family-sensitive content: This page discusses allegations involving child grooming, sexual exploitation, and abuse. Readers can skip directly to the resources section or FAQ if they prefer. The Roblox lawsuit update has continued to develop since this page was first published in June 2026. The latest publicly available JPML monthly report reviewed for [...]

If you developed a serious infection following orthopedic surgery — such as a hip or knee replacement — and a Bair Hugger forced-air warming device was used in the operating room, you may have grounds for a Bair Hugger lawsuit. As of October 1, 2026, 8,424 cases were pending in MDL 2666, and no settlement [...]

Quick Answer: A Depo-Provera settlement was announced on June 15, 2026, covering a majority of the claims in MDL 3140 and New York state court that the injectable birth control caused meningioma brain tumors. The parties signed a confidential Master Settlement Agreement on July 21, 2026 and estimated that roughly 80% of MDL plaintiffs would [...]

Update — September 24, 2026: On July 27, 2026, Johnson & Johnson proposed a $5.5 billion resolution of ovarian cancer talc claims, conditioned on participation by claimants representing at least 95% of the remaining claims. It does not cover mesothelioma: J&J says it has already settled about 95% of filed mesothelioma lawsuits. The Red River [...]

Mesothelioma guide 2026: what causes it, symptoms to watch, treatment options, and the legal routes to compensation, including lawsuits, asbestos trust funds and VA benefits.

Talcum powder and ovarian cancer in 2026: what the science actually shows (including the IARC’s 2024 “probably carcinogenic” classification), J&J’s proposed $5.5 billion resolution, who qualifies and how to file.

Update — September 24, 2026: A settlement has been reached. On June 15, 2026, plaintiffs’ leadership counsel announced a settlement with Pfizer of a majority of the claims in Depo-Provera MDL 3140 — before Judge M. Casey Rodgers in the U.S. District Court for the Northern District of Florida — and in New York state [...]

Depo-Provera brain tumor claims allege that long-term use of injectable medroxyprogesterone acetate raises the risk of intracranial meningioma and that patients were never adequately warned. Who qualifies in 2026: the diagnosis and use history required, the records that matter, and filing deadlines.